MinTech Industries

10/04/2025

10/03/2025

Creating 3 regiments of 99%+ thymoquinone cyclodextrin complexes. Known to create an additional 60% terminal oxidative stress loads specifically in hypoxic cancerous environment. Kind of expensive, but effectiveness and satisfaction is guaranteed. 2 other options available to safety to triple oxidative load in highly targeted environments. Always welcoming open conversation and insight.

06/09/2025

New logo

10/21/2024

Our first investigational medicine will be a anti-cancer drug called Quinoxal. Preclinical trials are set to start in about 18 months. Stay posted to see how this wonderful option can impact you and your loved ones

10/18/2024

Just starting my experimental medicine company. Hope you accept the invite, we have a lot of work to do...